TerminatedNot Applicable

International Multicenter Study on Lipin-1 Deficiency

Stopped: limited number of participating centers, due to regulatory burden and disease rarity.

France12 participantsStarted 2023-11-24

Plain-language summary

LIPIN1 is an international registry that allows the collection of data on the follow-up, management and treatment of patients with Lipin-1 deficiency.

Who can participate

Age range12 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patient at least 12 months with Lipin1 deficiency confirmed by molecular biology (two causal mutations in the LPIN1 gene) Exclusion Criteria: Opposition of the patient or his parents to participate to the study

What they're measuring

Evaluation of survival in patients with Lipin-1 deficiency

Timeframe: According to routine care

Trial details

NCT IDNCT05564520

SponsorImagine Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-24

View on ClinicalTrials.gov More Lipin-1 Deficiency trials